Cargando…
The DNMT3A R882H mutant displays altered flanking sequence preferences
The DNMT3A R882H mutation is frequently observed in acute myeloid leukemia (AML). It is located in the subunit and DNA binding interface of DNMT3A and has been reported to cause a reduction in activity and dominant negative effects. We investigated the mechanistic consequences of the R882H mutation...
Autores principales: | Emperle, Max, Rajavelu, Arumugam, Kunert, Stefan, Arimondo, Paola B, Reinhardt, Richard, Jurkowska, Renata Z, Jeltsch, Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887309/ https://www.ncbi.nlm.nih.gov/pubmed/29518238 http://dx.doi.org/10.1093/nar/gky168 |
Ejemplares similares
-
Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
por: Emperle, Max, et al.
Publicado: (2019) -
The DNMT3A R882H mutation does not cause dominant negative effects in purified mixed DNMT3A/R882H complexes
por: Emperle, Max, et al.
Publicado: (2018) -
Chromatin-dependent allosteric regulation of DNMT3A activity by MeCP2
por: Rajavelu, Arumugam, et al.
Publicado: (2018) -
Structural and biochemical insight into the mechanism of dual CpG site binding and methylation by the DNMT3A DNA methyltransferase
por: Emperle, Max, et al.
Publicado: (2021) -
The acute myeloid leukemia variant DNMT3A Arg882His is a DNMT3B-like enzyme
por: Norvil, Allison B, et al.
Publicado: (2020)